A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.
about
A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A randomised, multi-centre pha ...... l): Study design and protocol.
@en
A randomized, multicentre phas ...... l): Study design and protocol.
@nl
type
label
A randomised, multi-centre pha ...... l): Study design and protocol.
@en
A randomized, multicentre phas ...... l): Study design and protocol.
@nl
prefLabel
A randomised, multi-centre pha ...... l): Study design and protocol.
@en
A randomized, multicentre phas ...... l): Study design and protocol.
@nl
P2093
P2860
P356
P1476
A randomised, multi-centre pha ...... l): Study design and protocol.
@en
P2093
David R Cornblath
Hans D Katzberg
Ingemar S J Merkies
P2860
P304
P356
10.1111/JNS.12267
P577
2018-04-26T00:00:00Z